COMPANY PROFILE

Intrinsic Therapeutics

Explore full profile

Medical device to improve outcomes in lumbar discectomy patients

Boston, United StatesFounded 2000Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2017

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Intrinsic Therapeutics

In-Thera is a pioneering company in the healthcare sector, specializing in innovative therapies for musculoskeletal disorders. The company primarily serves patients suffering from conditions such as herniated discs, offering advanced medical solutions to enhance patient outcomes. Operating in the medical technology market, In-Thera focuses on developing and providing cutting-edge treatments that address chronic pain and improve quality of life. The business model revolves around research and development, clinical trials, and partnerships with healthcare providers to bring their therapies to market. Revenue is generated through the sale of their proprietary medical devices and treatment solutions, as well as through collaborations with medical institutions.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2000
Headquarters: Boston, United States
Employees: 92
Open positions: None listed
Dealroom signal: 78.1/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Patient Care, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning Intrinsic Therapeutics.

See all news

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GROWTH EQUITY NON VCOther financing	Mar 2021	$38M	—	Undisclosed	↗
DEBTDebt	May 2017	$28M	—	Quadrille Capital · Centre for Genomic Regulation · NEA · Delos Capital	—

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Intrinsic Therapeutics website traffic

Latest recorded traffic for Intrinsic Therapeutics is 0 monthly website visits. Intrinsic Therapeutics's team grew 15% over the past year.

Latest monthly visits0 1-year team growth+15%

Monthly website visitsJan 2017–May 2020

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
LBLocate BioRegenerative orthobiologics for bone and cartilage repair	Nottingham, United Kingdom	Operational	27	$32M	—
SMSadra MedicalFocused on developing minimal invasive alternatives to surgical valve replacement and improve patient care	Campbell, United States	Acquired
LILimbixPrescription digital therapeutics for adolescent mental health	Palo Alto, United States	Acquired
MOmoveUPAI-powered digital therapy for remote patient monitoring	City of Brussels, Belgium	Operational
VGVentureMed GroupEndovascular products to treat patients suffering from peripheral artery disease (PAD)	Toledo, United States	Operational
MEMedisieveMagnetic blood filtration enhancing gene therapy efficacy.	London, United Kingdom	Operational
IRImmersive RehabVirtual reality platform for digital neurorehabilitation therapeutics	London, United Kingdom	Operational
ITIDEV TechnologiesDevelops and commercializes medical devices for use in interventional radiology, vascular surgery, and cardiology	Webster, United States	Acquired